Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Cronos Group Inc.TSX: CRON.TO

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses growth accelerates

Q1 FY2026 operating expenses of $19.85M rose 18.2% year over year, ahead of the -22.8% change in trailing-twelve-month operating expenses. Sequentially, it fell 6.2% from the prior quarter. Over 3 fiscal years it compounded at -14.7% a year.

Context

  • Operating expenses amounted to 53.3% of revenue in FY2025, down 37.7 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +18.2% holds above the trailing-twelve-month pace of -22.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$19.85M-6.2% QoQ
Last fiscal yearDec 2025
$79.54M-25.6% YoY
LTMMar 2026
$79.67M-22.8% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+18.2%——
1 year-25.6%——
3-year CAGR-14.7%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
79.54M USD
Year-over-year change
-25.6%
4-year CAGR
-26.5%

Operating Expenses vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -22.8% is the lowest of 6, against a peer median of +5.0%.
  • Operating expenses amounts to 50.0% of revenue for CRON.TO, versus a peer median of 34.6%.
CRON.TO Competitors
Operating Expenses for CRON.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRY.TOTilray Brands, Inc.LTM Feb 2026$1.72B USD+76.0%+127.0%200.3%
EXE.TOExtendicare Inc.LTM Jun 2026CA$990.68M CAD-5.2%+6.4%50.1%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$420.05M CAD+2.5%+13.8%28.5%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$176.75M CAD+5.0%-0.5%34.6%
CRON.TOCronos Group Inc.LTM Mar 2026$79.67M USD-22.8%-14.7%50.0%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$45.24M CAD+19.2%+9.5%4.1%
Peer median (excluding CRON.TO) —+5.0%+9.5%34.6%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue64.02M87.54M87.03M117.5M149.15M
Cost of Revenue81.47M71.96M75.15M87.05M87.45M
Gross Profit(17.45M)15.58M11.88M30.45M61.7M
Gross Margin-27.3%17.8%13.7%25.9%41.4%
Research & Development21.66M13.25M5.83M4.22M4.53M
Selling, General & Admin120.67M101.64M80.74M76.74M75.01M
Operating Expenses272.09M128.01M96.48M106.91M79.54M
Depreciation & Amortization13.36M11.52M7.44M8.84M14.48M
EBITDA(150.79M)(93.81M)(72.28M)(45.37M)(2.94M)
EBITDA Margin-235.5%-107.2%-83.0%-38.6%-2.0%
Operating Income(289.54M)(112.44M)(84.6M)(76.46M)(17.84M)
Operating Margin-452.2%-128.4%-97.2%-65.1%-12.0%
Interest Income8.92M21.84M52.07M49.52M40.66M
Interest Expense00000
Other Income / Expenses162.1M(9.66M)11.1M113.01M419.21K
Income Before Tax(127.44M)(122.1M)(73.49M)36.55M(17.42M)
Pre-Tax Margin-199.1%-139.5%-84.4%31.1%-11.7%
Income Tax Expense(427.41K)34.48M(3.23M)(3.44M)(14.44M)
Net Income(392.81M)(170.26M)(73.79M)41.04M(9.61M)
Net Margin-613.5%-194.5%-84.8%34.9%-6.4%
EPS (Basic)(0.34)(0.42)(0.18)0.10(0.03)
EPS (Diluted)(0.34)(0.42)(0.18)0.10(0.03)
Weighted Avg Shares369.73M370.39M380.96M382.16M383.47M
Weighted Avg Shares (Diluted)370.39M370.39M380.96M382.16M383.47M

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.